Egis Pharmaceuticals PLC

Egis Pharmaceuticals PLC

Featured Exhibitors

Information

Egis is a leading Hungarian generic pharmaceutical company with over 110 years of experience. In 2023/2024 financial year, Egis Group generated net sales of nearly EUR 693 million. We cover the full value chain—from R&D and API/FP manufacturing to marketing in 60+ countries. At Egis, besides simple generics, we deliver value-added generic and highly potent products through advanced chemistry, streamlined production, and strong IP expertise. Our portfolio includes 653 products focused on cardiovascular, CNS, diabetes, dermatology, oncology and wound care.
Exhibitor Type
Exhibitor
Organization Type
Manufacturer/Innovator
Country
Hungary
Zone
Integrated Pharma
Markets Active In
North America (USA, Canada)Middle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Products and Services
Finished Dosage Forms (Products)Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)
Product Types
Finished Dosage Forms (Products)
Service Types
Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)
Product Categories
  • Finished Dosage Forms
    • Out-licensing

    Internal section - Visit/Docu integration

    VisitBooth
    7D74
    VisitExhibiting Name
    Egis Pharmaceuticals PLC
    VisitCountry
    HU
    Reference ID
    0014P000039GdKBQA0

    Social media

    Contact details

    https://www.egis.health
    Hungary

    Join the event!

    See all the content and easy-to-use features by logging in or registering!